Viewing nowCozaar Tablets (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Boryung Biopharma Co., Ltd.

MFDS item code 201902543 · Approved 2019.04.23
Treatment of hypertension and nephropathy in patients with type 2 diabetes mellitus and hypertension
This medicine is used to treat hypertension. It is particularly helpful in treating kidney disease in patients with type 2 diabetes and hypertension. It effectively controls hypertension, contributing to the protection of kidney function. Therefore, it is used for the improvement of hypertension and related kidney diseases.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be divided and administered orally twice daily, or the dose may be increased to 100 mg once daily, if necessary. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive medicine (e.g., a low-dose diuretic). An additive effect has been observed with concomitant use of hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily, depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used glucose-lowering medicines (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). No adjustment of the initial dose is necessary in patients 75 years of age or younger. For patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have intravascular volume depletion (e.g., patients receiving diuretic treatment), an initial dose of 25 mg of this medicine once daily is recommended (see section on precautions for use). A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents aged 6 years or older, weighing 20 kg or more and less than 50 kg, who are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years or older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be stopped immediately upon confirmation of pregnancy. It should not be used in patients with an allergy to this medication, those who are pregnant, patients with severely impaired liver function, certain genetic disorders, and patients with specific kidney diseases. Elderly patients, those with elevated blood potassium levels, mildly impaired liver function, patients with heart valve disease, and patients with cardiovascular disease should use this medication cautiously, as there is a risk of excessive blood pressure drop. During the use of this medication, side effects such as dizziness, muscle cramps, lower back pain, cough, and dyspepsia may occur, and serious allergic reactions, liver function abnormalities, and renal failure may rarely occur, so any abnormal symptoms should be reported to a physician immediately. Patients with impaired liver function may have elevated blood concentrations of this medication, so dosage adjustments may be needed, and patients with impaired kidney function should regularly monitor kidney status and electrolyte levels through blood tests. This medication may cause dangerously elevated blood potassium levels when taken with other antihypertensive agents, certain diuretics, and potassium supplements, so it is essential to consult a physician when used in combination with these drugs. In addition, grapefruit juice should be avoided while taking this medication, and it is advisable not to take it within 24 hours before surgery. It is recommended that breastfeeding be discontinued when taking this medication, and it should not be used in children under 6 years old or in children with severely impaired kidney function. Finally, during the use of this medication, dizziness or fainting due to blood pressure drop may occur, so caution is advised when driving or operating machinery and other hazardous activities.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. It is recommended to store it at room temperature between 1°C and 30°C. Proper storage will help maintain the medication's efficacy safely.
White oval film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
Boryung Biopharma Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.